Virus discharge and initial gastrointestinal involvement are negatively associated with circulating lymphocyte count in COVID-19
Background: It’s reported SARS-CoV-2 could transmit via gastrointestinal tract, with or without pulmonary symptoms. However, as far as we know, there is no convenient marker to predict the virus discharge in stool and initial gastrointestinal involvement of COVID-19.
Aims: We aimed to investigate the biomarker predicting virus discharge in stool and initial gastrointestinal involvement of COVID-19, which may assist the clinicians to better combat and prevent COVID-19.
Methods: The patients complained of initial gastrointestinal involvement, including vomiting, diarrhea, with or without respiratory symptoms, attending the Sixth People’s Hospital of Wenzhou, and the Second Affiliated Hospital of Wenzhou Medical University, were screened by qRT-PCR for SARS-CoV-2. The Confirmed COVID-19 patients without contaminated ingestion were all enrolled to investigate the association between circulating lymphocyte count and virus discharge, initial gastrointestinal involvement.
Results: 76 COVID-19 patients were finally enrolled in this study (mean age 44.5, male 44.7%), with 24 (31.5%) complained of initial gastrointestinal symptoms. Significantly lower circulating lymphocyte count was found in the patients with positive results of qRT-PCR on stool (p = 0.012). Furthermore, when the circulating lymphocyte count increased from bottom tertile to the 2nd and 3rd tertiles, the risk of initial gastrointestinal involvement decreased by nearly 75% (OR = 0.25, 95% CI: 0.07, 0.98, p = 0.047), 83% (OR = 0.17, 95% CI: 0.05, 0.63, p = 0.008), adjusted for possible confounders.
Conclusions: The circulating lymphocyte count is negatively associated with virus discharge in stool in COVID-19 patients, and the risk of initial gastrointestinal involvement also.
Biomarker of COVID-19 is very helpful for monitoring and diagnosing SARS-CoV. But yet there is no convenient marker currently to be used during clinical therapy. This study shows that circulating lymphocyte count is a promising parameter for diagnose initial gastrointestinal involvement and virus discharge of COVID-19, providing a novel strategy for predicting the stages of COVID-19 development. It should be very beneficial in both research and clinical community in combating COVID-19.
This research is informative in combating and preventing COVID-19. Indeed, it’s difficult to predict virus discharge via gastrointestinal tract, a convenient marker is urgently needed in clinics. As mentioned in the manuscript, the receptor for SARS-CoV is widely expressed in the site of mucosal membrane, leading gastrointestinal tract involved initially in the process of COVID-19. Therefore, a biomarker predicting initial gastrointestinal involvement is called for by clinicians. Overall, I recommend acceptance of the manuscript.
Posted 07 Jul, 2020
A preceding low-virulence strain pandemic inducing immunity against COVID-19
A pragmatic randomized controlled trial reports the efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Face mask use among individuals who are not medically diagnosed with COVID-19: A lack of evidence for and against and implications around public health recommendations.
Cumulative oxygen deficit is a novel biomarker for the timing of invasive mechanical ventilation in COVID-19 patients with respiratory distress: a time-dependent propensity score analysis
Differential Diagnosis of Multiple Primary and Intra-lung Metastasis of Lung Cancer by Multiple Gene Detection
AIDS and COVID-19 are two diseases separated by a common lymphocytopenia